Clinical Trials

To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and providing national leadership in testing these new therapies.

Advancing cancer care

Karmanos Cancer Institute is the only National Cancer Institute (NCI)-designated comprehensive cancer center in metro Detroit and one of just 53 centers of its kind in the United States. That means patients can access treatments exclusive to Karmanos as well as clinical trials, cancer prevention programs and multidisciplinary teams of cancer specialists — a comprehensive approach you cannot find at a community hospital. Because comprehensive cancer centers are at the forefront of cancer research, they can often handle patient cases that are more complex.

View Clinical Trials Request Appointment Online Call 1-800-KARMANOS

Highest Quality of Care

To receive the NCI designation, a hospital must demonstrate expertise in research, laboratory, clinical and population-based research. Hospitals must also provide early-phase clinical trials and conduct community outreach and educational activities. Karmanos is conducting more than 800 cancer-specific scientific investigation programs and clinical trials.

The scientific advances Karmanos researchers make every day help determine treatment options and guide treatment courses. We’re at the forefront of offering treatments that define the new standards of care. Our research programs, which are unique to Karmanos, are bringing safe, effective and groundbreaking treatments from the laboratory bench to the patient’s bedside. In fact, Karmanos offers more cancer treatments not found elsewhere in Michigan.

Setting the standards for cancer care

From groundbreaking research to the most up-to-date therapies and individualized treatment plans, Karmanos is truly leading the fight against cancer.

We’re committed to being at the forefront of cancer treatment and offering tomorrow’s standard of care today.



KCI Trials App

The Barbara Ann Karmanos Cancer Institute has an app for the iPhone® and iPad®, giving you information about our cutting-edge, cancer clinical trials.

The KCI Trials App is FREE and available on the App Store!

apple app download
 

App Features:

  • Search for cancer clinical trials at Karmanos Cancer Institute by disease site, keyword, protocol number, phase, or principal investigator
  • Protocol information displayed includes: title, objective, principal investigator, disease sites, drugs involved, inclusion criteria, exclusion criteria
  • Option to save protocol information to your 'favorites' and email protocol information to a colleague or patient
  • Buttons to call and email us directly
  • Information about Phase I studies offered at Karmanos Cancer Institute
  • Links to other National Cancer Institute resources about cancer

More Information

If you have any questions, concerns or problems regarding this app, please email informatics@karmanos.org.

Patient Stories

Gene Hodulik

Karmanos Cancer Institute

The fight against cancer requires a team of experts and careful planning.

Baljinder Khuban

Karmanos Cancer Institute

Baljinder Khuban, a resident of Strongsville, Ohio, was 35 when she was told she had non-curable cancer.

Lisa Bartolone

Karmanos Cancer Institute

The Barbara Ann Karmanos Cancer Institute is proud to recognize June as Cancer Survivor Month.
See All Patient Stories

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Why skin cancer plagues some Michigan counties more than others

The Detroit News Steven Daveluy, M.D., FAAD , dermatologist and member of the Melanoma Multidisciplinary Team at Karmanos, comments on the shortag...

Read More

IN THE NEWS: Simple lung cancer screening test is easy, painless - and could save your life

Detroit Free Press A Karmanos lung cancer survivor who smoked for over 30 years shares his journey of diagnosis and treatment with the Detroit Fre...

Read More

By the numbers: Lung cancer

Already one of the most common forms of cancer, lung cancer is also the leading cause of cancer death. “Early detection of lung cancer plays a cru...

Read More
News

ASCO Education – Impact of Implicit Racial Bias on Oncology Patient Care and Outcomes

Listen Now

OncLive On Air - Dr. Cole Shares Insights on Culturally Relevant Myeloma Care

Listen Now

OncLive On Air - Dr. Deol on the Importance of a Well-Rounded Fellowship Experience

Listen Now